Organizing Committee

MEET THE KEY OPINION LEADERS BEHIND ISCT 2025

The ISCT 2025 program is curated through the global collaboration of leading CGT experts that make up the ISCT 2025 Planning Faculty. Under the strategic leadership of our six esteemed Meeting Co-Chairs, the program addresses critical developments in CGT and educates delegates on both emerging trends and key innovations shaping the sector through two key streams: our Translational Pathway Program and our Roundtable Program each with its own dedicated planning committee.

 ISCT 2025 PLANNING FACULTY 

ISCT leaders with expertise spanning CGT translation responsible for oversight of planning and execution of full ISCT 2025 scientific program, ensuring ISCT 2025 serves as a platform to showcase the latest science and innovation, and a forum to develop solutions to critical challenges facing the sector.

 ISCT 2025 TRANSLATIONAL PATHWAY PROGRAM CO-CHAIRS 

The Translational Pathway Program is curated by ISCT key opinion leaders to showcase the new developments that will shape the future of our sector.
Through keynote presentations and talks, our leaders will offer insights into novel data and advancements on the horizon of the field.

SCIENCE & INNOVATION

Addresses scientific advances, emerging cell and cell-based therapeutic platforms, as well as technological developments
in pre-clinical CGT research with clinical implications.

TRANSLATION TO CLINIC

This segment addresses topics arising in moving from pre-clinical research to First in Human studies, including results from promising Phase I clinical trials, process development, clinical trial development with an eye to eventual market-authorization and product launch, early-stage CMC, regulatory requirements, and sustainable business models.

FROM FIRST IN HUMAN TO CLINICAL ACCELERATION

Addresses topics arising in moving from Phase I of clinical trials through to marketing authorization, including results of promising Phase II/III clinical trials, discussions of regulatory requirements and barriers to approval, COGs, business models and operational structures to scale up, partnering and investment.

LAUNCH & PATIENT ACCESS

Addresses topics arising in bringing about the clinical adoption of market-authorized CGT products for patients globally, for example, discussions on pricing and reimbursement, business models, scaling up and scaling out, global launch strategies, and real-world evidence.

  ISCT 2025 ROUNDTABLE PROGRAM CO-CHAIRS 

Our Roundtable Program provides an interactive forum for delegates to engage in in-depth discussions and generate solutions to specific real-world challenges in the CGT sector. By working closely with over 40 ISCT standing committees, the Roundtable Committee ensures that sessions reflect the practical needs and experiences of professionals from across the CGT spectrum.

ROUNDTABLE COMMITTEE